166 related articles for article (PubMed ID: 36456483)
1. [Efficacy of dienogest versus gonadotropin-releasing hormone agonist combined with dienogest sequential therapy in the treatment of adenomyosis].
Zhang HY; Zhu S; Xu W; Wang AQ; Wang XL
Zhonghua Fu Chan Ke Za Zhi; 2022 Nov; 57(11):856-863. PubMed ID: 36456483
[No Abstract] [Full Text] [Related]
2. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
Ji M; Yuan M; Jiao X; Li Q; Huang Y; Li J; Wang G
Gynecol Endocrinol; 2022 Feb; 38(2):164-169. PubMed ID: 34749585
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice.
Miao J; Lu J; Tang J; Lu P
Gynecol Endocrinol; 2022 Aug; 38(8):656-660. PubMed ID: 35850637
[No Abstract] [Full Text] [Related]
4. Maintenance dienogest therapy following adjuvant gonadotropin-releasing hormone agonist treatment after uterus-sparing surgery in adenomyosis: A retrospective cohort study.
Chan IS; Hsu TF; Shih YC; Chang YH; Wang PH; Chen YJ
Int J Gynaecol Obstet; 2023 Jun; 161(3):751-759. PubMed ID: 36527263
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the efficacy of GnRH-a pretreatment before total hysterectomy for adenomyosis patients: a propensity score matching analysis].
Chen MG; Zhao ML; Fu HL; Mao M; Wang Q; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2023 Aug; 58(8):589-594. PubMed ID: 37599256
[No Abstract] [Full Text] [Related]
6. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
Guo Y; Duan H; Cheng J; Zhang Y
BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
[TBL] [Abstract][Full Text] [Related]
7. Comparison of efficacy between levonorgestrel intrauterine system and dienogest in adenomyosis: a randomized clinical trial.
Choudhury S; Jena SK; Mitra S; Padhy BM; Mohakud S
Ther Adv Reprod Health; 2024; 18():26334941241227401. PubMed ID: 38283750
[TBL] [Abstract][Full Text] [Related]
8. Compare the Efficacy of Dienogest and the Levonorgestrel Intrauterine System in Women with Adenomyosis.
Guo W; Lin Y; Hu S; Shen Y
Clin Ther; 2023 Oct; 45(10):973-976. PubMed ID: 37599165
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the safety of dienogest in women with adenomyosis: A retrospective analysis.
Ono N; Asano R; Nagai K; Sugo Y; Nakamura T; Miyagi E
J Obstet Gynaecol Res; 2021 Apr; 47(4):1433-1440. PubMed ID: 33590656
[TBL] [Abstract][Full Text] [Related]
10. Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis.
Chu Z; Jia L; Dai J; Wu Q; Tian F; Bai S
J Ovarian Res; 2024 Jan; 17(1):16. PubMed ID: 38216945
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest.
Takagi H; Takakura M; Sasagawa T
Taiwan J Obstet Gynecol; 2023 Nov; 62(6):852-857. PubMed ID: 38008504
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis.
Pang LL; Mei J; Fan LX; Zhao TT; Li RN; Wen Y
Front Public Health; 2021; 9():688264. PubMed ID: 34485218
[No Abstract] [Full Text] [Related]
13. Efficacy, Adverse Events, and Challenges of Dienogest in the Management of Symptomatic Adenomyosis: A Comparison with Different Hormonal Treatments.
Kobayashi H
Gynecol Obstet Invest; 2023; 88(2):71-80. PubMed ID: 36682346
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
Matsushima T; Akira S; Yoneyama K; Takeshita T
Gynecol Endocrinol; 2020 Jun; 36(6):521-524. PubMed ID: 31661345
[TBL] [Abstract][Full Text] [Related]
15. [Value of using gonadotropin-releasing hormone agonist pretreatment in adenomyosis patients before adenomyomectomy].
Tan AL; Luo RY; Gong M
Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):909-913. PubMed ID: 28057126
[No Abstract] [Full Text] [Related]
16. [Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis].
Ye MZ; Deng XL; Zhu XG; Xue M
Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):643-649. PubMed ID: 27671043
[No Abstract] [Full Text] [Related]
17. Dienogest in conjunction with GnRH-a for postoperative management of endometriosis.
Ma Y; Wang WX; Zhao Y
Front Pharmacol; 2024; 15():1373582. PubMed ID: 38515854
[No Abstract] [Full Text] [Related]
18. Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial.
Sharma S; RoyChoudhury S; Bhattacharya MP; Hazra S; Majhi AK; Oswal KC; Chattopadhyay R
Reprod Biomed Online; 2023 Jul; 47(1):84-93. PubMed ID: 37149412
[TBL] [Abstract][Full Text] [Related]
19. Application of modified subtotal resection of adenomyosis combined with LNG-IUS and GnRH-a sequential therapy in severe adenomyosis: A case series.
Qin Z; Dong Z; Tang H; Zhang S; Wang H; Bao M; Wei W; Shi R; Chen J; Xia B
Front Surg; 2022; 9():914725. PubMed ID: 36061067
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the final menstrual period in women taking Dienogest using estradiol and follicle-stimulating hormone values: a case-control study.
Uehara M; Wada-Hiraike O; Koga K; Yamamoto N; Hirano M; Harada M; Hirota Y; Osuga Y
Endocr J; 2022 Dec; 69(12):1437-1445. PubMed ID: 36070964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
